Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Arrhythmogenic right ventricular disease]

J Brachmann1, T Hilbel, W Schöls

  • 1Abteilung Innere Medizin III, Medizinische Universitätsklinik Heidelberg.

Zeitschrift Fur Kardiologie
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative analysis of cryoballoon versus radiofrequency catheter ablation in atrial fibrillation patients with impaired left ventricular ejection fraction.

International journal of cardiology. Heart & vasculature·2025
Same author

Editorial: Current proceedings in magnetocardiology-past, present, future.

Frontiers in cardiovascular medicine·2024
Same author

Sensitivity of temperature-based time since death estimation on measurement location.

International journal of legal medicine·2023
Same author

Delayed occurrence of traumatic aortic dissection? Biomechanical considerations and literature.

International journal of legal medicine·2022
Same author

Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[On pathogenesis of coronary heart disease].

Zeitschrift fur Kardiologie·2016
Same journal

An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Reconstructive surgery of the aortic root].

Zeitschrift fur Kardiologie·2016
See all related articles

Arrhythmogenic right ventricular disease (ARVD) causes life-threatening arrhythmias and sudden death, primarily in young adults. Early diagnosis via advanced imaging and tests can reduce arrhythmia risk with targeted therapy.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Context:

  • Arrhythmogenic right ventricular disease (ARVD) is a primary inherited cardiomyopathy.
  • Pathological hallmarks include progressive fibrolipomatous replacement of the right ventricular myocardium.
  • ARVD poses a significant risk for sudden cardiac death, especially in adolescents and young adults under 40.

Purpose:

  • To outline the clinical presentation, diagnostic challenges, and management strategies for arrhythmogenic right ventricular disease.
  • To emphasize the importance of early diagnosis for risk stratification and therapeutic intervention.

Summary:

  • ARVD is characterized by ventricular arrhythmias and sudden cardiac death, often before age 40.
  • Progressive fibrolipomatous myocardial replacement in the right ventricle is pathognomonic.

Related Experiment Videos

  • Diagnosis requires comprehensive investigations including cineangiography, biopsy, MRI, and electrophysiological studies.
  • Early diagnosis enables risk reduction through tailored antiarrhythmic therapy.

    • Impact:

    • Highlights the critical need for advanced diagnostic modalities in identifying ARVD.
    • Underscores the potential to mitigate life-threatening arrhythmias and sudden cardiac death through timely intervention.
    • Informs clinical practice regarding the recognition and management of this challenging cardiac condition.